Related references
Note: Only part of the references are listed.The roles of c-Jun NH2-terminal kinases (JNKs) in obesity and insulin resistance
Martin Pal et al.
JOURNAL OF PHYSIOLOGY-LONDON (2016)
Molecular and cellular mechanisms linking inflammation to insulin resistance and beta-cell dysfunction
Hadi Khodabandehloo et al.
TRANSLATIONAL RESEARCH (2016)
Roles of Chemokines and Chemokine Receptors in Obesity-Associated Insulin Resistance and Nonalcoholic Fatty Liver Disease
Liang Xu et al.
BIOMOLECULES (2015)
Type 2 diabetes mellitus: Role of melatonin and oxidative stress
Doddigarla Zephy et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2015)
FFA-induced hepatic insulin resistance in vivo is mediated by PKCδ, NADPH oxidase, and oxidative stress
Sandra Pereira et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2014)
Up-Regulation of Urotensin II and Its Receptor Contributes to Human Hepatocellular Carcinoma Growth via Activation of the PKC, ERK1/2, and p38 MAPK Signaling Pathways
Xiao-Tong Yu et al.
MOLECULES (2014)
Urotensin II Inhibits Skeletal Muscle Glucose Transport Signaling Pathways via the NADPH Oxidase Pathway
Hong-Xia Wang et al.
PLOS ONE (2013)
Mitofusin-2 ameliorates high-fat diet-induced insulin resistance in liver of rats
Ke-Xin Gan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Genetic and Pharmacological Manipulation of Urotensin II Ameliorate the Metabolic and Atherosclerosis Sequalae in Mice
Zhipeng You et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
A closer look at the role of urotensin II in the metabolic syndrome
Pierre-Olivier Barrette et al.
Frontiers in Endocrinology (2012)
Oxidative stress and the etiology of insulin resistance and type 2 diabetes
Erik J. Henriksen et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Elevated expression of urotensin II and its receptor in diethylnitrosamine-mediated precancerous lesions in rat liver
Hongxia Wang et al.
PEPTIDES (2011)
Urotensin II differentially regulates macrophage and hepatic cholesterol homeostasis
Robert S. Kiss et al.
PEPTIDES (2011)
Role of urotensin II in health and disease
Bryan Ross et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2010)
NOX3-derived reactive oxygen species promote TNF-α-induced reductions in hepatocyte glycogen levels via a JNK pathway
Lanfang Li et al.
FEBS LETTERS (2010)
The Effects of Palmitate on Hepatic Insulin Resistance Are Mediated by NADPH Oxidase 3-derived Reactive Oxygen Species through JNK and p38MAPK Pathways
Dan Gao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Role of Reactive Oxygen Species in the Progression of Type 2 Diabetes and Atherosclerosis
Hideaki Kaneto et al.
MEDIATORS OF INFLAMMATION (2010)
Hepatic insulin resistance, metabolic syndrome and cardiovascular disease
Reza Meshkani et al.
CLINICAL BIOCHEMISTRY (2009)
Human Urotensin II Promotes Hypertension and Atherosclerotic Cardiovascular Diseases
Takuya Watanabe et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Characterization of the insulinostatic effect of urotensin II: A study in the perfused rat pancreas
Ramona A. Silvestre et al.
REGULATORY PEPTIDES (2009)
Elevated expression of urotensin II and its receptor in skeletal muscle of diabetic mouse
Hong Xia Wang et al.
REGULATORY PEPTIDES (2009)
Resistin induces insulin resistance by both AMPK-dependent and AMPK-independent mechanisms in HepG2 cells
Zhaofan Luo et al.
ENDOCRINE (2009)
Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-κB activation via NADPH oxidase
Yongzhong Wei et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Angiotensin II-induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells
Yongzhong Wei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Proteome of H-411E (liver) cells exposed to insulin and tumor necrosis factor-α:: Analysis of proteins involved in insulin resistance
SS Solomon et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2005)
Human urotensin II is a novel activator of NADPH oxidase in human pulmonary artery smooth muscle cells
T Djordjevic et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascular complications in a model of insulin resistance, the fructose-fed rat
S Delbosc et al.
ATHEROSCLEROSIS (2005)
Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide
H Kaneto et al.
NATURE MEDICINE (2004)
Modulation of the JNK pathway in liver affects insulin resistance status
Y Nakatani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Interleukin-6 induces cellular insulin resistance in hepatocytes
JJ Senn et al.
DIABETES (2002)
A central role for JNK in obesity and insulin resistance
J Hirosumi et al.
NATURE (2002)
Effects of berberine on glucose metabolism in vitro
J Yin et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2002)
Share Paper
